NCT02467270 Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of Doses Status COMPLETED Phase PHASE2
NCT02461160 Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants Study Status COMPLETED Phase PHASE1
NCT02457247 Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation. Status COMPLETED Phase PHASE4
NCT02454426 Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease Status WITHDRAWN Phase EARLY_PHASE1
NCT02451150 A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With Hypertension Status COMPLETED Phase PHASE3
NCT02443922 Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM Status UNKNOWN Phase NA
NCT02442752 Phase 1 Dexlansoprazole Delayed-Release Capsules for Acid-Related Disorders in Infants Aged 1 to 11 Months Status WITHDRAWN Phase PHASE1
NCT02430870 TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE1
NCT02427958 A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese Participants Status COMPLETED Phase PHASE4
NCT02425111 Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's Disease Status COMPLETED Phase PHASE3
NCT02425098 Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in Singapore Status COMPLETED Phase PHASE2
NCT02415712 Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance) Status COMPLETED Phase N/A
NCT02413255 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02410499 Efficacy and Safety of Weekly Subcutaneous MLN1202 in Improving Diabetic Nephropathy in Participants With Macroalbuminuria Status WITHDRAWN Phase PHASE2
NCT02400775 A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. Status WITHDRAWN Phase PHASE4